HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sukhdeep Grewal Selected Research

N-benzyladriamycin-14-valerate (AD 198)

2/2016Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells.
10/2013N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sukhdeep Grewal Research Topics

Disease

2Lymphoma (Lymphomas)
02/2016 - 10/2013
2Neoplasms (Cancer)
02/2016 - 10/2013
2Multiple Myeloma
02/2016 - 10/2013
1Osteoarthritis
01/2022
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2016
1Atherosclerosis
07/2015
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2013

Drug/Important Bio-Agent (IBA)

2TNF Receptor-Associated Factor 3IBA
02/2016 - 10/2013
2N-benzyladriamycin-14-valerate (AD 198)IBA
02/2016 - 10/2013
1oridoninIBA
02/2016
1Bortezomib (Velcade)FDA Link
02/2016
1Pharmaceutical PreparationsIBA
02/2016
1AntibodiesIBA
07/2015
1EpitopesIBA
07/2015
1AntigensIBA
07/2015
1Apolipoproteins E (ApoE)IBA
07/2015
1Immunoglobulin M (IgM)IBA
07/2015
1Therapeutic UsesIBA
10/2013
13-ingenyl angelateIBA
10/2013

Therapy/Procedure

1Therapeutic Embolization
01/2022